Body mass index trajectories during infancy and pediatric obesity at 6 years

Jun Xiu Liu1, Ji Hong Liu1, Edward A Frongillo2

  • 1Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia.

Annals of Epidemiology
|November 28, 2017
PubMed

Insights

A high-stable body mass index (BMI) trajectory in infancy increases the risk of childhood obesity by age 6. However, this trajectory has limited accuracy in identifying children who will become obese.

Area of Science:

  • Pediatrics
  • Public Health
  • Growth Monitoring

Background:

  • Childhood obesity is a significant public health concern.
  • Early life factors, including body mass index (BMI) trajectories, may influence later obesity risk.
  • Understanding infant BMI patterns can inform early intervention strategies.

Purpose of the Study:

  • To investigate the association between infant body mass index (BMI) trajectories and the risk of obesity at age 6 years.
  • To identify distinct patterns of BMI change during the first year of life.
  • To determine if specific BMI trajectories predict later obesity development.

Main Methods:

  • Utilized data from 1169 children with multiple BMI measurements in the first year of life.
  • Employed latent class growth analysis to identify infant BMI trajectories.
  • Used logistic regression to assess the link between identified trajectories and obesity at age 6.

Main Results:

  • Identified three infant BMI trajectories: low stable (80.2%), high stable (16.9%), and rising (2.8%).
  • The high-stable trajectory group had the highest prevalence of obesity at age 6 (17.2%).
  • Children with a high-stable trajectory showed a 1.79 times higher odds of obesity at age 6 compared to the low-stable group.

Conclusions:

  • A high-stable BMI trajectory during infancy is associated with an increased risk of obesity at age 6.
  • While indicating higher risk, the high-stable trajectory demonstrated low accuracy in pinpointing children who would be obese at age 6.
  • Further research may be needed to refine predictive models for childhood obesity based on early life growth patterns.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
337
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
278
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
257